TY  - GEN
AU  - Li,Rui
AU  - Hu,Zhongliang
AU  - Sun,Shi-Yong
AU  - Chen,Zhuo G
AU  - Owonikoko,Taofeek K
AU  - Sica,Gabriel L
AU  - Ramalingam,Suresh S
AU  - Curran,Walter J
AU  - Khuri,Fadlo R
AU  - Deng,Xingming
TI  - Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer
SN  - 1538-8514
PY  - 2014///0519
KW  - Apoptosis
KW  - drug effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Drug Resistance, Neoplasm
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Mutation
KW  - Niclosamide
KW  - administration & dosage
KW  - Phosphorylation
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - genetics
KW  - Quinazolines
KW  - STAT3 Transcription Factor
KW  - biosynthesis
KW  - Signal Transduction
KW  - Xenograft Model Antitumor Assays
KW  - bcl-X Protein
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1535-7163.MCT-13-0095
ER  -